Home
1
Products
2
FUNJAPIN POWDER FOR IV Inj. (MAXIPIME) 3
Home Product ANITIBIOTICS SUlFONAMIDES FUNJAPIN POWDER FOR IV Inj. (MAXIPIME)
135

FUNJAPIN POWDER FOR IV Inj. (MAXIPIME)

DOH PM 049340


< COMPOSITION >
Each vial contains:
Cefepime…….................…1g(potency)

< ACTION >
Cefepime is a fourth-generation cephalosporin antibiotic developed in 1994. Cefepime is active against Gram-positive and Gram-negative bacteria, with greater activity against both than third-generation antibiotics. Cefepime is usually reserved to treat severe nosocomial pneumonia, infections caused by multi-resistant microorganisms (e.g. Pseudomonas aeruginosa) and empirical treatment of febrile neutropenia.

< INDICATION >
For the treatment of pneumonia (moderate to severe) caused by Streptococcus pneumoniae, including cases associated with concurrent bacteremia, Pseudomonas aeruginosa, Klebsiella pneumoniae, or Enterobacter species. Also for empiric treatment of febrile neutropenic patients and uncomplicated and complicated urinary tract infections (including pyelonephritis) caused by Escherichia coli or Klebsiella pneumoniae, when the infection is severe, or caused by Escherichia coli, Klebsiella pneumoniae, or Proteus mirabilis, when the infection is mild to moderate, including cases associated with concurrent bacteremia with these microorganisms. Also for the treatment of uncomplicated skin and skin structure infections caused by Staphylococcus aureus (methicillin-susceptible strains only) or Streptococcus pyogenes and complicated intra-abdominal infections (used in combination with metronidazole) caused by Escherichia coli, viridans group streptococci, Pseudomonas aeruginosa, Klebsiella pneumoniae, Enterobacter species, or Bacteroides fragilis.

< USAGE AND ADMINISTRATION >
Treatment of moderate-to-severe pneumonia: 1-2 g IV q8-12hr for 7-10 days (if not caused by Pseudomonas) or for up to 21 days. Empiric therapy in febrile neutropenic patients: 2 g IV q8hr for 7 days or until neutropenia resolves. Treatment of uncomplicated and complicated urinary tract infections (UTIs), including pyelonephritis: 0.5-1 g IV or IM q12hr for 7-10 days.  Severe UTIs due to Escherichia coli or Klebsiella pneumoniae: 2 g IV q12hr for 10 days. Treatment of uncomplicated skin and skin structure infections: 2 g IV q12hr for 10 days. Treatment of complicated intra-abdominal infections; use in combination with metronidazole: 2 g IV q12hr for 7-10 days.

< PACKAGE >
1g(potency)/vial, 1vial/box

ANITIBIOTICS SUlFONAMIDES 1084747